Cereblon Modulators
Showing 1 - 25 of 174
Hematological Malignancies Trial in Beijing, Tianjin (TQB3820 tablets)
Recruiting
- Hematological Malignancies
- TQB3820 tablets
-
Beijing, Beijing, China
- +1 more
Sep 18, 2021
Ibd CAncer and seRious Infections in France (I-CARE 2)
Not yet recruiting
- IBD
- +2 more
- Non-interventional
-
Amiens, France
- +1 more
Oct 13, 2023
Incidence of Cereblon in Intensive Care Patients
Not yet recruiting
- Critical Illness
- Sepsis
- (no location specified)
Oct 6, 2021
A Post-Authorization, Long-term Study of Ozanimod Real-world
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
-
Bethesda, MarylandEvidera
Oct 31, 2022
Prospective Study of Pregnancy in Women With Cystic Fibrosis
Recruiting
- Pregnancy Related
- Cystic Fibrosis
-
Birmingham, Alabama
- +39 more
Jan 26, 2023
Effectiveness of CFTR Modulators According to Co-therapy
Not yet recruiting
- Cystic Fibrosis
- Discontinuation of respiratory co-therapy (azithromycin, RhDNase, or inhaled antibiotics)
- (no location specified)
Dec 15, 2022
Cystic Fibrosis Trial in Birmingham (Symdeko)
Recruiting
- Cystic Fibrosis
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 30, 2022
Multiple Sclerosis COVID-19/Vaccination Treated With Ofatumumab
Completed
- Multiple Sclerosis
-
East Hanover, New JerseyNovartis
Jul 14, 2023
Fitness, Body Composition, Physical Activity and Sleep Patterns
Recruiting
- Cystic Fibrosis
-
Portsmouth, United KingdomUniversity of Portsmouth
May 16, 2023
CFTR Modulators and Gastrointestinal Complications
Active, not recruiting
- Cystic Fibrosis
- +6 more
- No intervention
-
Nottingham, United KingdomNottingham University Hospitals NHS Trust
Jul 7, 2022
Stress Trial in Plymouth (Chaga Mushroom, Algae Extract, Black Cumin Seed Oil)
Completed
- Stress
- Chaga Mushroom
- +5 more
-
Plymouth, Massachusetts3 Waves Wellness, LLC
Aug 18, 2022
CFTR Modulators (VOLATIL-CF)
Not yet recruiting
- Cystic Fibrosis
- exhaled breath collection
- Data collection
-
Paris, Ile-de-France, FranceHôpital Necker - Enfants malades
Feb 3, 2023
Alzheimer Trial in Brescia (Gamma tACS (40 Hz) over the superior parietal cortex, Sham tACS over the superior parietal cortex)
Completed
- Alzheimer Disease
- Gamma tACS (40 Hz) over the superior parietal cortex
- Sham tACS over the superior parietal cortex
-
Brescia, BS, ItalyAO Spedali Civili
Nov 17, 2022
Biological & Clinical Effects of Significantly Corrected CFTR
Active, not recruiting
- Cystic Fibrosis
- Ivacaftor or elexacaftor/tezacaftor/ivacaftor
-
Birmingham, Alabama
- +33 more
Feb 2, 2022
Cystic Fibrosis Transmembrane Regulator Biomarker Study to
Recruiting
- Cystic Fibrosis
- Treatment with cystic fibrosis transmembrane regulator (CFTR) modualtors Ivacaftor, Lumacaftor-Ivacaftor, Tezacaftor-Ivacaftor, Elexacaftor-Tezacaftor-Ivacaftor
-
Berlin, Germany
- +3 more
Apr 1, 2022
Pemphigus Vulgaris Trial in Wuhan (Abatacept Prefilled Syringe, Mycophenolate Mofetil 500Mg Tab)
Recruiting
- Pemphigus Vulgaris
- Abatacept Prefilled Syringe
- Mycophenolate Mofetil 500Mg Tab
-
Wuhan, Hubei, ChinaTongji Hospital
Mar 20, 2022
Obesity Trial in Tallahassee (Normobaric hypoxia (NH), Normobaric normoxia (NN))
Not yet recruiting
- Obesity
- Normobaric hypoxia (NH)
- Normobaric normoxia (NN)
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 15, 2022
CFTR Modulators in Pregnant Individuals and in Postpartum
Not yet recruiting
- Cystic Fibrosis
- Pregnancy
-
Minneapolis, MinnesotaUniversity of Minnesota
Jan 6, 2023
Osteoporosis and Fragility Fractures Among SLE Patients.
Recruiting
- Lupus Erythematosus, Systemic
- DXA
- +2 more
-
Verona, ItalyAOUI Verona - UOC Reumatologia
Oct 18, 2022
Sickle Cell Disease, Dyslipidemia, Complication Trial in Pointe-à-Pitre, Le Lamentin (HDL2)
Recruiting
- Sickle Cell Disease
- +2 more
- HDL2
-
Pointe-à-Pitre, Guadeloupe, France
- +1 more
Mar 21, 2023
